We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $268M
1-Year Est. Return 158.98%
This Fund
S&P 500
This Quarter Est. Return
+2.11%
1 Year Est. Return
+158.98%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$119M
AUM Growth
-$1.36M
Cap. Flow
+$6.26M
Cap. Flow %
5.25%
Top 10 Hldgs %
39.35%
Holding
221
New
78
Increased
37
Reduced
38
Closed
48

Top Buys

1
IBIT icon
iShares Bitcoin Trust
IBIT
+$7.97M
2
CNC icon
Centene
CNC
+$7.51M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$4.8M
4
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$2.61M
5
LLY icon
Eli Lilly
LLY
+$2.51M

Top Sells

1
HUM icon
Humana
HUM
+$9.46M
2
DVA icon
DaVita
DVA
+$5.09M
3
WBA
Walgreens Boots Alliance
WBA
+$3.51M
4
CAH icon
Cardinal Health
CAH
+$2.43M
5
DFS
Discover Financial Services
DFS
+$1.87M

Sector Composition

1 Healthcare 60.53%
2 Financials 20.86%
3 Materials 3.73%
4 Energy 1.78%
5 Industrials 0.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALT icon
126
CALL
Altimmune
ALT
$558M
$65.2K 0.05%
961
+359
+60% +$2.27K
AGIO icon
127
CALL
Agios Pharmaceuticals
AGIO
$2.36B
$64.7K 0.05%
310
– –
PRQR icon
128
ProQR Therapeutics
PRQR
$240M
$63.6K 0.05%
+47,783
New +$102K
RARE icon
129
CALL
Ultragenyx Pharmaceutical
RARE
$2.88B
$61K 0.05%
270
+112
+71% +$4.66K
ZYME icon
130
CALL
Zymeworks
ZYME
$1.78B
$56.9K 0.05%
+418
New +$5.7K
MNKD icon
131
CALL
MannKind Corp
MNKD
$1.25B
$53.9K 0.05%
+1,197
New +$6.71K
PFE icon
132
CALL
Pfizer
PFE
$143B
$53.4K 0.04%
2,085
+1,548
+288% +$40.5K
NVO
133
CALL
Novo Nordisk
NVO
$223B
$52.2K 0.04%
251
-285
-53% -$23.5K
ELDN icon
134
Eledon Pharmaceuticals
ELDN
$314M
$50.4K 0.04%
14,855
– –
KRE icon
135
CALL
State Street SPDR S&P Regional Banking ETF
KRE
$4.97B
$47.1K 0.04%
1,520
+898
+144% +$54.6K
ALNY icon
136
PUT
Alnylam Pharmaceuticals
ALNY
$35.7B
$43K 0.04%
+46
New +$11.8K
QURE icon
137
CALL
uniQure
QURE
$2.77B
$42.8K 0.04%
+354
New +$4.96K
NKTR icon
138
CALL
Nektar Therapeutics
NKTR
$2.31B
$36.7K 0.03%
104
– –
CRSP icon
139
CALL
CRISPR Therapeutics
CRSP
$4.71B
$36.5K 0.03%
+258
New +$10.9K
TERN
140
DELISTED
Terns Pharmaceuticals
TERN
$35.3K 0.03%
12,807
– –
SGMT icon
141
Sagimet Biosciences
SGMT
$483M
$34.5K 0.03%
+10,597
New +$44.4K
CADL icon
142
Candel Therapeutics
CADL
$746M
$33.4K 0.03%
5,918
-128
-2% -$1.05K
KALV
143
CALL
DELISTED
KalVista Pharmaceuticals
KALV
$32.5K 0.03%
+241
New +$2.46K
CRDF icon
144
CALL
Cardiff Oncology
CRDF
$60.2M
$26.4K 0.02%
+479
New +$1.89K
FOLD
145
CALL
DELISTED
Amicus Therapeutics
FOLD
$23.5K 0.02%
303
– –
SPY icon
146
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$21.5K 0.02%
55
-472
-90% -$277K
ATYR
147
CALL
aTyr Pharma
ATYR
$50M
$17.9K 0.02%
+126
New +$459
MRNA icon
148
CALL
Moderna
MRNA
$24.5B
$17.1K 0.01%
134
– –
UBX
149
PUT
DELISTED
Unity Biotechnology
UBX
$15.5K 0.01%
+511
New +$923
CORT icon
150
PUT
Corcept Therapeutics
CORT
$9.72B
$13.2K 0.01%
346
+345
+34,500% +$21K
4 5
6
7 8

Similar funds

VC
VarCov Co Darien, Connecticut $268M AUM
AL
AIP LLC New York $268M AUM 40.4% 1-Year Est. Return
FC
Foursixthree Capital New York $268M AUM 115.24% 1-Year Est. Return
NF
Nvest Financial Portsmouth, New Hampshire $268M AUM 22.87% 1-Year Est. Return
PF
Prosperitas Financial Valencia, California $268M AUM 32.64% 1-Year Est. Return
UI
Untitled Investments New York $269M AUM 11.35% 1-Year Est. Return
SSWM
Strait & Sound Wealth Management San Francisco, California $269M AUM 22.03% 1-Year Est. Return
AC
Applied Capital Little Rock, Arkansas $268M AUM 16.92% 1-Year Est. Return

Persistent Asset Partners's Q1 2025 Portfolio in Review

As of Q1 2025, Persistent Asset Partners held 221 positions worth $119M, down 1.1% from $121M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Persistent Asset Partners deployed $6.26M of net new capital in Q1 2025, opening 78 new positions and adding to 37 existing holdings. Its largest new stake was iShares Bitcoin Trust: 150,623 shares worth $7.05M.

By sector, the portfolio is most concentrated in Healthcare at 61% of assets, down from 68% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was Humana, an estimated $9.46M trimmed.

  • Persistent Asset Partners's largest Q1 2025 buy was iShares Bitcoin Trust: 150,623 shares worth $7.05M.
  • Persistent Asset Partners added most to Centene in Q1 2025, an estimated $7.51M increase.
  • Persistent Asset Partners's biggest Q1 2025 reduction was Humana, cutting an estimated $9.46M.
  • Persistent Asset Partners fully exited Walgreens Boots Alliance in Q1 2025, selling an estimated $3.51M.
  • Persistent Asset Partners's ten largest holdings make up 39% of its $119M portfolio in Q1 2025.
  • Persistent Asset Partners opened 78 new positions and closed 48 in Q1 2025.
  • Persistent Asset Partners's portfolio value fell 1.1% quarter-over-quarter to $119M.

Based on Persistent Asset Partners's 13F filing for Q1 2025, filed 13 May 2025.